VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARDT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARDTArdent Health Inc.
$17.75$2.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARDTP/E History

ARDT logoArdent Health Inc. (ARDT) P/E Ratio History

Premium Valuation

Trading at 17.2x vs 5Y avg 12.4x · 78th percentile · Premium to historical baseline · Data 2024–2026

Current P/E (TTM)
17.2x
+39% vs 5Y avg
5Y Avg P/E
12.4x
Median 9.2x
5Y Percentile
78th
Upper end of range
PEG Ratio
N/A
5-Year P/E Range
17.2x
Min7.3xMedian9.2xMax29.4x
TTM EPS$1.03
Price$17.75
Earnings Yield5.81%
EPS Growth (1Y)-39.2%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of November 18, 2026, Ardent Health Inc. (ARDT) trades at a price-to-earnings ratio of 17.2x, with a stock price of $17.75 and trailing twelve-month earnings per share of $1.03.

The current P/E is 39% above its 5-year average of 12.4x. Over the past five years, ARDT's P/E has ranged from a low of 7.3x to a high of 29.4x, placing the current valuation at the 78th percentile of its historical range.

Compared to the Healthcare sector median P/E of 25.0x, ARDT trades at a 31% discount to its sector peers. The sector includes 249 companies with P/E ratios ranging from 0.0x to 184.2x.

Relative to the broader market, ARDT trades roughly in line with the S&P 500 median P/E of 21.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARDT DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ARDT Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
17.2vs25.0
-31%
Below Sector
vs. S&P 500
17.2vs21.5
-20%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -39% EPS growth (1Y)

ARDT P/E vs Peers

Hospital Operators peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HCA logoHCAHCA Healthcare, Inc.
$109B16.10.76+29%
THC logoTHCTenet Healthcare Corporation
$24B7.80.24Best-53%
UHS logoUHSUniversal Health Services, Inc.
$12B7.8Lowest0.48+37%
ENSG logoENSGThe Ensign Group, Inc.
$11B27.62.00+14%
MCK logoMCKMcKesson Corporation
$127B27.1-+49%Best
CAH logoCAHCardinal Health, Inc.
$65B35.81.26+12%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

ARDT Historical P/E Data (2024–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q3Sep 30 2026$10.34$1.0310.0x-19%
FY2026 Q2-$9.84$0.5517.9x+45%
FY2026 Q1-$8.56$0.959.0x-27%
FY2025 Q4Dec 31 2025$8.83$0.969.2x-26%
FY2025 Q3-$13.25$1.508.8x-28%
FY2025 Q2Jun 30 2025$13.66$1.867.3x-41%
FY2025 Q1Mar 31 2025$13.75$1.648.4x-32%
FY2024 Q4-$17.08$1.5411.1x-10%
FY2024 Q3Sep 30 2024$18.38$0.6329.4x+138%

Average P/E for displayed period: 12.4x

Export Data
Consensus & Technical Research Suite
Open ARDT Terminal

ARDT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

2+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ARDT — Frequently Asked Questions

Quick answers to the most common questions about buying ARDT stock.

What is ARDT's P/E ratio?

Ardent Health Inc. (ARDT) trailing twelve-month P/E ratio is 17.2x, based on TTM diluted EPS of $1.03. The 5-year average P/E is 12.4x and the historical range spans 7.3x to 29.4x.

Is ARDT stock overvalued or undervalued?

ARDT trades at 17.2x P/E, above its 5-year average of 12.4x. The 78th percentile ranking within the 7.3x–29.4x historical range indicates a premium to historical valuation.

Is ARDT stock expensive?

Yes, ARDT is expensive relative to its own history. The current P/E of 17.2x is above the 5-year average of 12.4x. The stock sits at the 78th percentile of its 5-year valuation range.

What is ARDT's historical P/E range?

Over the past 5 years, ARDT's P/E ratio has ranged from 7.3x to 29.4x, with a median of 9.2x and an average of 12.4x. The current P/E of 17.2x places the stock at the 78th percentile of this range. Full historical data spans 2024–2026.

How does ARDT's P/E compare to the S&P 500?

ARDT trades at 17.2x P/E versus the S&P 500 median of 21.5x. The 20% discount to the market suggests lower growth expectations or perceived higher risk.

How does ARDT's valuation compare to Healthcare peers?

Ardent Health Inc. P/E of 17.2x compares to the Healthcare sector median of 25.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is ARDT's PEG ratio?

ARDT PEG ratio is N/A, based on a P/E of 17.2x and EPS growth of -39.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is ARDT's earnings yield?

ARDT earnings yield is 5.81%, the inverse of its 17.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

ARDT P/E Ratio History (2024–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current10.0x
Period Avg12.4x
Range7.3x - 29.4x
Change-66%
9 quartersSep 30, 2024 - Sep 30, 2026